Woldeamanuel, Y. W. Rapoport, A. M. and Cowan, R. P. 2014. What Is the Evidence for the Use of Corticosteroids in Migraine?. Current Pain and Headache Reports, Vol. 18, Issue. 12,

Coyle, Doug Lee, Karen M. Mamdani, Muhammad Sabarre, Kelley‐Anne and Tingley, Kylie 2015. Reimbursement‐Based Economics – What Is It and How Can We Use It to Inform Drug Policy Reform?. Headache: The Journal of Head and Face Pain, Vol. 55, Issue. S4, p. 236.

Cameron, Chris Kelly, Shannon Hsieh, Shu‐Ching Murphy, Meghan Chen, Li Kotb, Ahmed Peterson, Joan Coyle, Doug Skidmore, Becky Gomes, Tara Clifford, Tammy and Wells, George 2015. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta‐Analysis. Headache: The Journal of Head and Face Pain, Vol. 55, Issue. S4, p. 221.

Ruggeri, Matteo Drago, Carlo Rosiello, Francesco Orlando, Valentina and Santori, Costanza 2020. Economic Evaluation of Treatments for Migraine: An Assessment of the Generalizability Following a Systematic Review. PharmacoEconomics, Vol. 38, Issue. 5, p. 473.

Martelletti, Paolo 2022. Migraine in Medicine. p. 1.

Dowell, Deborah Ragan, Kathleen R. Jones, Christopher M. Baldwin, Grant T. and Chou, Roger 2022. CDC Clinical Practice Guideline for Prescribing Opioids for Pain—United States, 2022. MMWR. Recommendations and Reports, Vol. 71, Issue. 3, p. 1.

Johnston, Karissa Harris, Linda Powell, Lauren Popoff, Evan Coric, Vladimir L’Italien, Gilbert and Schreiber, Curtis P. 2022. Monthly migraine days, tablet utilization, and quality of life associated with Rimegepant – post hoc results from an open label safety study (BHV3000–201). The Journal of Headache and Pain, Vol. 23, Issue. 1,